---
title: "Indian Acrylics Ltd (514165) — Share Price, Financials & Analysis"
symbol: "514165"
company: "Indian Acrylics Ltd"
canonical: "https://tapetide.com/stocks/514165"
isin: "INE862B01013"
nse_symbol: "INDIANACRYLICSLTD"
bse_code: "514165"
sector: "Chemicals"
industry: "Petrochemicals"
market_cap_cr: 79.28
generated_at: "2026-09-13T19:41:15.910Z"
---

# Indian Acrylics Ltd (514165)

Canonical page: https://tapetide.com/stocks/514165

## Company

- **NSE Symbol:** INDIANACRYLICSLTD
- **BSE Code:** 514165
- **ISIN:** INE862B01013
- **Sector:** Chemicals
- **Industry:** Petrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **CEO:** Mr. Surinder Kansal
- **Employees:** 1447
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** indianacrylics.com

## About

Incorporated in 1996, Indian Acrylics Ltd is in the business of manufacturing both acrylic fiber and yarn.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:41:33.352399Z.

- **Market Cap:** ₹79.28 Cr
- **Classification:** Microcap
- **P/E (reported):** -3.7
- **EPS (TTM):** ₹-1.54
- **EPS (reported):** ₹0
- **Book Value:** ₹-0.91
- **Price to Book:** -6.36
- **Dividend Yield:** 0%
- **ROE:** -306.13%
- **ROCE:** -7.01%
- **Debt to Equity:** 7.28
- **Revenue (yearly):** ₹351.68 Cr
- **Net Income:** ₹-24.09 Cr
- **EBITDA:** ₹-1.32 Cr
- **52-Week High:** ₹8.88
- **52-Week Low:** ₹3.52
- **RSI (14):** 48.54

## Tapetide Score

- **Score:** 34 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 4.9 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 12.74 | 9% |
| growth | 39.23 | 9% |
| momentum | 73.43 | 12% |
| ownership | 50 | 24% |
| quality | 27.11 | 22% |
| valuation | 18.27 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -7.74% over past five years.
- Promoters have pledged 26.4% of their holding.
- Earnings include an other income of Rs.6.23 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -210.78% | -117.81% | -185.13% |
| ebitda margin growth | 188.1% | -208.82% | -67.26% | -86.69% |
| net income growth | 85.09% | -22.04% | -55.47% | -68.34% |
| revenue growth | 43.44% | -10.83% | -27% | -8% |
| roce | -118.79% | -41.63% | -130.14% | -0.02% |
| roe | -85.38% | 130.42% | -139.29% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 171.59 | 130.22 | 106.34 | 114.16 | 95.88 | 96.36 | 82.92 | 86.19 | 102.19 | 89.3 | 74 | 106.94 |
| Expenses | 184.58 | 127.12 | 110.19 | 115.54 | 99.84 | 95.02 | 82.66 | 86.28 | 100.41 | 85.95 | 80.36 | 105.6 |
| Operating Profit | -12.99 | 3.1 | -3.85 | -1.38 | -3.96 | 1.34 | 0.26 | -0.09 | 1.78 | 3.35 | -6.36 | 1.34 |
| OPM % | -7.57 | 2.38 | -3.62 | -1.21 | -4.13 | 1.39 | 0.31 | -0.1 | 1.74 | 3.75 | -8.59 | 1.25 |
| Other Income | 1.21 | 1.6 | 1.71 | 2.8 | 0.72 | 1.21 | 0.36 | 1.86 | 0.25 | 1.48 | 2.15 | 2.35 |
| Interest | 9.14 | 8.43 | 6.45 | 6.5 | 4.57 | 4.33 | 3.15 | 3.67 | 4.94 | 4.22 | 4.45 | 2.98 |
| Depreciation | 3.81 | 3.91 | 3.76 | 3.69 | 3.69 | 3.13 | 3.16 | 2.82 | 2.84 | 2.81 | 2.75 | 2.38 |
| Profit before tax | -24.73 | -7.64 | -12.35 | -8.77 | -11.5 | -4.91 | -5.69 | -4.72 | -5.75 | -2.2 | -11.41 | -1.67 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -24.74 | -7.64 | -12.34 | -8.77 | -11.49 | -4.91 | -5.69 | -4.72 | -5.75 | -2.2 | -11.42 | -1.67 |
| EPS in Rs | -1.83 | -0.56 | -0.91 | -0.65 | -0.85 | -0.36 | -0.42 | -0.35 | -0.42 | -0.16 | -0.84 | -0.12 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 523 | 731 | 744 | 526 | 618 | 902 | 546 | 389 | 352 | 372 |
| Expenses | 486 | 701 | 677 | 467 | 641 | 838 | 561 | 393 | 353 | 372 |
| Operating Profit | 36 | 30 | 67 | 59 | -23 | 65 | -15 | -3 | -1 | 0 |
| OPM % | 7 | 4.1 | 9 | 11 | -3.7 | 7 | -2.7 | -0.9 | -0.4 | 0 |
| Other Income | 8 | 28 | 4 | 8 | 6 | 7 | 8 | 5 | 6 | 6 |
| Interest | 20 | 28 | 38 | 35 | 34 | 37 | 32 | 19 | 17 | 17 |
| Depreciation | 16 | 18 | 22 | 25 | 25 | 16 | 15 | 14 | 11 | 11 |
| Profit before tax | 9 | 12 | 11 | 6 | -76 | 19 | -54 | -31 | -24 | -21 |
| Tax % | 0 | 6 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net Profit | 9 | 12 | 11 | 6 | -76 | 19 | -54 | -31 | -24 | -21 |
| EPS in Rs | 0.65 | 0.86 | 0.79 | 0.46 | -5.62 | 1.42 | -3.99 | -2.28 | -1.78 | -1.54 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 |
| Reserves | -37 | -15 | -3 | 7 | 13 | -62 | -43 | -95 | -125 | -148 |
| Borrowings | 147 | 204 | 205 | 214 | 216 | 216 | 184 | 187 | 183 | 231 |
| Other Liabilities | 177 | 172 | 241 | 263 | 211 | 310 | 282 | 171 | 179 | 134 |
| Total Liabilities | 422 | 496 | 577 | 618 | 575 | 600 | 558 | 398 | 372 | 352 |
| Fixed Assets | 193 | 228 | 218 | 288 | 273 | 254 | 242 | 226 | 207 | 194 |
| CWIP | 1 | 11 | 58 | 11 | 3 | 2 | 1 | 1 | 1 | 1 |
| Investments | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 227 | 258 | 301 | 319 | 299 | 343 | 315 | 171 | 165 | 158 |
| Total Assets | 422 | 496 | 577 | 618 | 575 | 600 | 558 | 398 | 372 | 352 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 15 | 4 | 76 | 101 | 11 | 87 | 53 | 9 | -10 | -30 |
| Cash from Investing Activity | -57 | -59 | -58 | -43 | -5 | -4 | -1 | 0 | 27 | 2 |
| Cash from Financing Activity | 46 | 40 | -18 | -54 | -11 | -37 | -74 | -36 | -17 | 34 |
| Net Cash Flow | 4 | -16 | 1 | 4 | -5 | 47 | -22 | -27 | 1 | 6 |
| Free Cash Flow | -42 | -56 | 19 | 58 | 6 | 84 | 52 | 9 | 18 | -28 |
| CFO/OP | 31 | 10 | 252 | 150 | 19 | -379 | 83 | -59 | 278 | 2277 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 37 | 26 | 19 | 13 | 12 | 14 | 11 | 12 | 15 | 17 |
| Inventory Days | 157 | 188 | 140 | 175 | 276 | 164 | 127 | 112 | 158 | 161 |
| Days Payable | 174 | 153 | 142 | 166 | 210 | 201 | 147 | 127 | 176 | 146 |
| Cash Conversion Cycle | 20 | 61 | 18 | 22 | 79 | -23 | -8 | -3 | -4 | 32 |
| Working Capital Days | 0 | 27 | 10 | 1 | 31 | -37 | -16 | -40 | -42 | -2 |
| ROCE % | 22 | 10 | 6 | 14 | 11 | -13 | 20 | -9 | -6 | -3 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 33.96% | 34.35% | 34.36% | 34.44% | 34.08% | 34.24% | 34.5% | 34.51% | 34.52% | 34.49% | 34.5% | 34.51% |
| Others | 3.41% | 3.02% | 3.01% | 2.93% | 3.29% | 3.13% | 2.87% | 2.86% | 2.85% | 2.88% | 2.87% | 2.85% |
| No. of Shareholders | 103530 | 103277 | 104258 | 104097 | 103759 | 103680 | 103502 | 103172 | 102906 | 102598 | 102343 | 102007 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 5.9 | Sell |
| EMA (10) | 5.89 | Sell |
| SMA (20) | 5.94 | Sell |
| EMA (20) | 5.91 | Sell |
| SMA (50) | 5.88 | Sell |
| EMA (50) | 5.89 | Sell |
| SMA (100) | 5.92 | Sell |
| EMA (100) | 5.9 | Sell |
| SMA (200) | 5.92 | Sell |
| EMA (200) | 6.14 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.83 | Neutral |
| MACD (12,26,9) | -0.01 | Sell |
| Stochastic (14,3,3) | 60.66 | Neutral |
| ADX (14) | 14.57 | Neutral |
| Williams %R (14) | -44.14 | Neutral |
| ATR (14) | 0.36 | High Volatility |
| ROC (12) | -5.84 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 46.54 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dfc0dcb-e1e1-4d0e-b125-6a818971c895.pdf) |
| 2026-09-02 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48bee567-81df-463d-9755-c9f0cdd0de66.pdf) |
| 2026-09-02 | [Intimation Of Letter To Shareholders Under Reg.36(1)(B) Of SEBI (LODR) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff6657e5-5644-4ef4-acea-43dfdc21a092.pdf) |
| 2026-08-24 | [Intimation Of Book Closure And Date Of Annual General Meeting E-Voting Facilities And Fixation Of CUT-OFF DATE.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=402ae7e8-5483-4e91-b051-bd7ae3183014.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14fa360c-7e38-43a1-8ec5-708a24377106.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 13.08.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=345a7683-de78-4e32-b55b-68409f0a43f0.pdf) |
| 2026-08-01 | [Board Meeting Intimation for 13/08/2026 To Consider And Approve Unaudited Financial Results For The Quarter Ended 30.06.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77d29947-8c9e-4eaa-8c70-4a6bc0737531.pdf) |
| 2026-07-06 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3428aef-e429-4845-8132-3e6dbd451f8b.pdf) |
| 2026-06-26 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41244321-8bbf-4a1b-a700-73cee60fed47.pdf) |
| 2026-05-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b531c6fb-a77e-4ef6-9d40-ba862f9aac2a.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Unaudited Financial Results For The Quarter Ended 30.06.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89b3d25a-2120-497e-bf9b-fa80afde59ad.pdf) |
| 2026-05-29 | [Audited Financial Results For The Quarter And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc33e298-82fe-43c2-80a0-60c244d8d4d8.pdf) |
| 2026-02-13 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7241ee61-b80e-4fc3-9f45-e76c5d4dbd82.pdf) |
| 2025-11-13 | [Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1e17fe2-e573-4938-a779-2ebbb594c2a4.pdf) |
| 2025-08-13 | [Unaudited Financial Results For The Quarter Ended 30.06.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1f29bdf-4a4f-4c5f-abfd-ad6433859a3d.pdf) |
| 2025-05-30 | [Financial Results For Quarter And Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fb8daac-534e-4420-bc86-8a60d005e73b.pdf) |
| 2025-05-30 | [Financial Results For The Quarter And Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a352f7b-e426-4dfa-a33d-cd8a85e480ba.pdf) |
| 2025-02-13 | [Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2024 Alongwith Limited Review Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eca2125-335a-46f5-b23d-c00afcd0c9ee.pdf) |
| 2024-11-13 | [Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c93d582-d63b-46d9-b598-7c42385e3677.pdf) |
| 2024-08-13 | [For Quarter Ending 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c44ce73-599c-4b5e-aa15-8a9d4f59b422.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 May - Board to meet on 29 May 2026 for audited Q4 and FY2026 results; trading window already closed. | [Board Meeting Intimation for Board Meeting Intimation For 29/05/2026 To Take On Record Audited Financial Results For The Quarter And Year Ended 31.03.2026. 8 May - Board to meet on 29 May 2026 for audited Q4 and FY2026 results; trading window already closed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/32211509-9d4b-45ab-bec8-dfc26d3ff5e4.pdf) |
| 6 Jan - Certificate under Reg 74(5): physical share certificates dematerialized and cancelled for quarter ended 31 December 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Jan - Certificate under Reg 74(5): physical share certificates dematerialized and cancelled for quarter ended 31 December 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f1a67104-763c-465a-9ca7-4d5c5a5fd706.pdf) |
| 4 Apr - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.03.2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4 Apr - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.03.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b711c65-0190-41f4-8f0b-6cb2a595fd50.pdf) |
| 31 Jan - CDSCO permits import/sale of Imfinzi (Durvalumab 120mg/500mg) for resectable GC/GEJC with FLOT. | [Intimation Under Regulation 30 Of SEBI (LODR) Regulation, 2015 31 Jan - CDSCO permits import/sale of Imfinzi (Durvalumab 120mg/500mg) for resectable GC/GEJC with FLOT.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cea2b465-8ea9-402e-93f2-75534becc080.pdf) |
| 28 Jan - Board meeting 13 Feb 2026 to record unaudited results for quarter and nine months ended 31/12/2025. | [Board Meeting Intimation for 13/02/2026 To Take On Record Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025. 28 Jan - Board meeting 13 Feb 2026 to record unaudited results for quarter and nine months ended 31/12/2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8afdec30-c410-4c1f-8f09-c54cb2091293.pdf) |
| 2 Feb - SES assigned ESG Score 64.4 (Grade B) for FY2024-25; report accessed Feb 2, 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Disclosure Of ESG Rating 2 Feb - SES assigned ESG Score 64.4 (Grade B) for FY2024-25; report accessed Feb 2, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f58a87ee-d2be-4010-9202-e5b06ba13cda.pdf) |
| 19 Feb - RTA certificate dated Feb 5, 2026 confirming compliance with Regulation 74(5), submitted by AstraZeneca Pharma India. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 19 Feb - RTA certificate dated Feb 5, 2026 confirming compliance with Regulation 74(5), submitted by AstraZeneca Pharma India.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/79cf196f-1100-46c0-9de2-253ca8e0d972.pdf) |
| 19 Feb - Newspaper publication of the Company pertaining to the unaudited financial results for the quarter ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Feb - Newspaper publication of the Company pertaining to the unaudited financial results for the quarter ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f3ffd3fb-466a-481b-b0dc-78c60d0c18a5.pdf) |
| 18 Feb - NSE Sustainability assigned AstraZeneca Pharma India an ESG rating of 70 for FY2024-25; report dated Feb 17, 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Disclosure Of ESG Rating 18 Feb - NSE Sustainability assigned AstraZeneca Pharma India an ESG rating of 70 for FY2024-25; report dated Feb 17, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9ddeec18-ef0d-4193-b7b5-a01c552ebf06.pdf) |
| 16 Feb - Newspaper publication of extract of unaudited financial results for the quarter and nine months ended 31.12.2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb - Newspaper publication of extract of unaudited financial results for the quarter and nine months ended 31.12.2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/418fd5cb-3b7f-4c6c-a15e-8659373a9f01.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_829_ASTRAZEN_2012_2013_30072013174501.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08c2022f-1184-41e7-839c-bf4352a3e535.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62704201-a568-45ff-8cdd-2f8f8bd6353c.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75c0cbf9-4e30-46d6-92f8-cf430e0ec2cc.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d39f0ddc-7749-493e-97dd-9406af5181ef.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9f65f0cd-5c2b-4b83-b480-de84bf5d341a.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2391045e-eda9-4c1d-84e7-3518a34838ba.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/506820/73732506820.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/514165/75341514165.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/506820/68949506820.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:41:15.910Z.